SCHEMBL2660460

SCHEMBL2660460

CN(C)c1cncs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12236716 0.74
SCHEMBL9959791 0.73 HDAC8 (0.32)
SCHEMBL12822609 0.73 KDM4E (0.36)
SCHEMBL27984646 0.69
SCHEMBL2976835 0.69 SLC6A3 (0.36)
SCHEMBL5798687 0.69 HDAC8 (0.38)
SCHEMBL27630804 0.66
SCHEMBL27856744 0.64 HDAC8 (0.37)
SCHEMBL740847 0.64
SCHEMBL6348870 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250368636-A1 NOVEL HETEROCYCLIC COMPOUND, SALT THEREOF, AND LUMINESCENT SUBSTRATE COMPOSITION THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) 2025-12-04 US disclosed
CN-115996914-B Novel heterocyclic compound and salt thereof, and luminescent substrate composition 国立大学法人电气通信大学 2024-06-07 CN disclosed
WO-2024091489-A1 FUSED AZINES AS DYNAMIN-1-LIKE PROTEIN INHIBITORS AND USES THEREOF MITOBRIDGE, INC. (US) 2024-05-02 WO disclosed
WO-2023238683-A1 NOVEL HETEROCYCLIC COMPOUND AND SALT THEREOF, AND LUMINESCENT SUBSTRATE COMPOSITION 国立大学法人電気通信大学 2023-12-14 WO disclosed
US-11807612-B2 Heterocyclic compound and salt thereof, and luminescent substrate composition THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) 2023-11-07 US disclosed
US-11807612-B2 Heterocyclic compound and salt thereof, and luminescent substrate composition THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) 2023-11-07 US disclosed
US-11807612-B2 Heterocyclic compound and salt thereof, and luminescent substrate composition THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) 2023-11-07 US disclosed
US-20230192635-A1 NOVEL HETEROCYCLIC COMPOUND AND SALT THEREOF, AND LUMINESCENT SUBSTRATE COMPOSITION THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) 2023-06-22 US disclosed
US-20230192635-A1 NOVEL HETEROCYCLIC COMPOUND AND SALT THEREOF, AND LUMINESCENT SUBSTRATE COMPOSITION THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) 2023-06-22 US disclosed
US-20230192635-A1 NOVEL HETEROCYCLIC COMPOUND AND SALT THEREOF, AND LUMINESCENT SUBSTRATE COMPOSITION THE UNIVERSITY OF ELECTRO-COMMUNICATIONS (JP) 2023-06-22 US disclosed
CN-102007116-B Pyridazinone glucokinase activators HOFFMAN-LA ROCHE LTD. (CH) 2014-10-22 CN disclosed
CN-102066384-B Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands BRISTOL MYERS SQUIBB CO 2014-07-30 CN disclosed
CN-102947311-A 3-oxo-3, 9-dihydro-1H-benzopyrano [2,3-C ] pyrroles as glucokinase activators HOFFMANN LA ROCHE 2013-02-27 CN disclosed
CN-102791718-A Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands BRISTOL MYERS SQUIBB CO 2012-11-21 CN disclosed
CN-102066384-A Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands BRISTOL MYERS SQUIBB CO 2011-05-18 CN disclosed
CN-102007118-A Pyrrolidinone glucokinase activators HOFFMANN LA ROCHE 2011-04-06 CN disclosed
CN-102007116-A Pyridazinone glucokinase activators HOFFMANN LA ROCHE 2011-04-06 CN disclosed
WO-2009127544-A1 PYRIDAZINONE GLUCOKINASE ACTIVATORS F. HOFFMANN-LA ROCHE AG (CH) 2009-10-22 WO disclosed
CN-101472902-A Novel piperazine compounds and their use as HCV polymerase inhibitors JAPAN TOBACCO INC (JP) 2009-07-01 CN disclosed
CN-101268043-A Amino-alkyl-amide derivatives as CCR3 receptor ligands SANOFI AVENTIS (FR) 2008-09-17 CN disclosed